An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo

Journal of Photochemistry and Photobiology B: Biology

Volumn 35, Issue 3, 1996, Pages 209-211

  Webber, John ^a   Luo, Yu ^a   Crilly, Richard ^a   Fromm, David ^a   Kessel, David ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALA; Apoptosis; Photodynamic therapy; Protoporphyrin

Indexed keywords

AMINOLEVULINIC ACID; DNA FRAGMENT; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLON TUMOR; CONTROLLED STUDY; GEL ELECTROPHORESIS; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARMUSTINE; COLONIC NEOPLASMS; DNA FRAGMENTATION; DOXORUBICIN; ETOPOSIDE; MICE; PACLITAXEL; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS;

ANIMALIA;

EID: 0030248768     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07291-0     Document Type: Article

References (24)

1. [1] J. Moan and K. Berg, Photochemotherapy of cancer: Experimental research, Photochem. Photobiol., 55 (1992) 931-948.
2. [2] B.W. Henderson and T.J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol., 55 (1992) 145-157.
3. [3] J.C. Kennedy and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol., 14 (1992) 275-292.
4. [4] J.C. Kennedy and R.H. Pottier, Using δ-aminolevulinic acid in cancer therapy, ACS Symp. Ser., 559 (1994) 291-302.
5. [5] J. Bedwell, A.J. MacRobert, D. Phillips and S.G. Bown, Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model, Br. J. Cancer, 65 (1992) 818-824.
6. [6] Q. Peng, J. Moan, T. Warloe, J.M. Nesland and C. Rimington, Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma, Int. J. Cancer, 52 (1992) 433-443.
7. [7] C.S. Loh, A.J. MacRobert, J. Bedwell, J. Regula, N. Krasner and S.G. Bown, Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy, Br. J. Cancer, 68 (1993) 41-51.
8. [8] B.W. Henderson, S.M. Waldow,T.S. Mang, W.R. Potter,P.B. Malone and T.J. Dougherty, Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy, Cancer Res., 45 (1985) 572-576.
9. [9] S.H. Selman, M. Kreimer-Birnbaum, P. Goldblatt, R.W. Keck and S.L. Britton, Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light, Cancer Res., 44 (1984) 1924-1927.
10. [10] D.J.H. Roberts, F. Cairnduff, I. Driver, B. Dixon and S.B. Brown, Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevulinic acid, Int. J. Oncol., 5 (1994) 763-768.
11. [11] J.F.R. Kerr, A.H. Wyllie and A.R. Currie, Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 26 (1972) 239-257.
12. [12] M.C. Raff, Social controls on cell survival and death, Nature, 356 (1992) 397-400.
13. [13] M.L. Agarwal, M.E. Clay, E.J. Harvey, H.H. Evans, A.R. Antunez and N.L. Oleinick, Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells, Cancer Res., 51 (1991) 5993-5996.
14. [14] X.-Y. He, R. Sikes, S. Thomsen, L.W.K. Chung and S.L. Jacques, Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines, Photochem. Photobiol., 59 (1994) 468-473.
15. [15] S.I.A. Zaidi, N.L. Oleinick, M.T. Zaim and H. Mukhtar, Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence, Photochem. Photobiol., 58 (1993) 771-776.
16. [16] T.H. Corbett, D.P. Griswold, Jr., B.J. Roberts, J.C. Peckham, F.M. Schabel, Jr., Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure, Cancer Res., 35 (1975) 2434-2439.
17. [17] T.H. Corbett, D.P. Griswold, Jr., B.J. Roberts, J.C. Peckham and F.M. Schabel, Jr., Evaluation of single agents and combination of chemotherapeutic agents in mouse colon carcinomas, Cancer, 405 (1977) 2660-2680.
18. [18] D. Kessel, Use of fluorescent probes for characterizing sites of photodamage, Spectrum, 6 (1993) 1-6.
19. [19] M.M. Gottesman and I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem., 62 (1993) 385-428.
20. [20] G.T. Williams, Programmed cell death: apoptosis and oncogenesis, Cell, 65 (1991) 1097-1098.
21. [21] J.A. Hickman, C.S. Potten, A.J. Merritt and T.C. Fisher, Apoptosis and cancer chemotherapy, Phil. Trans. R. Soc. London B, 345 (1994) 319-325.
22. [22] R.S. Chapman, A.D. Whetton and C. Dive, The suppression of drug-induced apoptosis by activation of v-ABL tyrosine kinase, Cancer Res., 54 (1994) 5131-5137.
23. [23] T.C. Fisher, A.E. Miller, C.D. Gregory, A.L. Jackman, G.W. Aherne, J.A. Hartley, C. Dive and J.A. Hickman, bcl-2 Modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathway, Cancer Res., 53 (1993) 3321-3326.
24. [24] C. Dive and J.A. Hickman, Drug-target interactions: only the first step in the commitment to a programmed cell death?, Br. J. Cancer, 64 (1994) 192-196.